Chronic obstructive pulmonary disease (COPD) is a lung condition that often hides in plain sight. You may think you're ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with ...

Verona Pharma’s flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...

Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in ...

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to ...